| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3076959 | Neurología Argentina | 2011 | 6 Pages |
Abstract
Beyond the immune component involved the disease is resistant to immunotherapies, there have been trials with different drugs, but the effectiveness of these therapies and their adverse effects require further evaluation.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Marcelo Rugiero, Mariela Bettini,